TGF-beta receptor type II fusion proteins and uses thereof

• 收藏
• 分享

专利权人:

Acceleron Pharma Inc.

发明人:

Kumar, Ravindra,Sako, Dianne S.

申请号：

AU2018261131

公开号：

AU2018261131A1

申请日:

2018.05.03

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

In certain aspects, the present disclosure relates to ΤβRΙΙ fusion polypeptides comprising a heterologous portion and a tnmcated, ligand-binding portion of the extracellular domain of TβRII polypeptide useful to selectively antagonize a TβRII Iigand. The disclosure further provides compositions and methods for use in treating or preventing ΤGFβ associated disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/